| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Beyond Medical Technologies Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.03 |
| 52 Week High | US$0.06 |
| 52 Week Low | US$0.03 |
| Beta | 6124.43 |
| 11 Month Change | -14.29% |
| 3 Month Change | 0% |
| 1 Year Change | -62.50% |
| 33 Year Change | -91.43% |
| 5 Year Change | -99.21% |
| Change since IPO | -99.59% |
Recent News & Updates
Recent updates
Shareholder Returns
| DOCT | CA Medical Equipment | CA Market | |
|---|---|---|---|
| 7D | 0% | -0.9% | 0.7% |
| 1Y | -62.5% | -12.4% | 20.5% |
Return vs Industry: DOCT underperformed the Canadian Medical Equipment industry which returned -12.4% over the past year.
Return vs Market: DOCT underperformed the Canadian Market which returned 20.5% over the past year.
Price Volatility
| DOCT volatility | |
|---|---|
| DOCT Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 10.6% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.0% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: DOCT's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine DOCT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Kal Malhi | www.beyond-md.ca |
Beyond Medical Technologies Inc. does not have significant operations. Previously, it was involved in the manufacture and distribution of personal protective equipment, such as medical grade face masks in Canada. The company was formerly known as Micron Waste Technologies Inc. Beyond Medical Technologies Inc. is headquartered in Vancouver, Canada.
Beyond Medical Technologies Inc. Fundamentals Summary
| DOCT fundamental statistics | |
|---|---|
| Market cap | CA$213.74k |
| Earnings (TTM) | -CA$434.55k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs DOCT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DOCT income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$434.55k |
| Earnings | -CA$434.55k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.055 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -13.8% |
How did DOCT perform over the long term?
See historical performance and comparison